ライフサイエンスコーパス: angiotensin I-converting enzyme

1 inc metalloprotease whose closest homolog is angiotensin I-converting enzyme.

2 ells expressing the SARS-CoV receptor, human angiotensin I converting enzyme 2 (hACE2).

3 e of the most widely studied is the gene for angiotensin I converting enzyme (ACE ).

4 he angiotensin II (Ang II)-breakdown enzyme, angiotensin I converting enzyme (ACE) 2, suggests the im

5 shed Amadori ketoses showed moderate to weak angiotensin I converting enzyme (ACE) inhibitory activit

6 identify peptides with dual antioxidant and angiotensin I converting enzyme (ACE) inhibitory activit

7 Angiotensin I converting enzyme (ACE) inhibitory and ant

8 he activity of the peptide inhibitors of the angiotensin I converting enzyme (ACE), and the antiradic

9 othelin 1 (EDN1); we assayed the activity of angiotensin I converting enzyme (ACE), which catalyses t

10 The most hydrolysed sample showed high angiotensin I converting enzyme (ACE)-inhibitory and ant

11 ddition to the extract's capacity to inhibit angiotensin I-converting enzyme (ACE) activity.

12 Using inhibitors of angiotensin I-converting enzyme (ACE) and CP, we show th

13 fraction of the heart and skeletal muscles, angiotensin I-converting enzyme (ACE) and neutral endope

14 g white, and (ii) evaluate the inhibition of angiotensin I-converting enzyme (ACE) by the obtained hy

15 n expended to determine whether the gene for angiotensin I-converting enzyme (ACE) confers susceptibi

16 The A-240T and I/D polymorphisms in the angiotensin I-converting enzyme (ACE) gene are markers o

17 Angiotensin I-converting enzyme (ACE) hydrolyzes numerou

18 Part of the beneficial effects of angiotensin I-converting enzyme (ACE) inhibitors are due

19 Angiotensin I-converting enzyme (ACE) inhibitors derived

20 To investigate how angiotensin I-converting enzyme (ACE) inhibitors enhance

21 Angiotensin I-converting enzyme (ACE) inhibitors have be

22 To investigate further the relationship of angiotensin I-converting enzyme (ACE) inhibitors to acti

23 es, majority of them were found identical to angiotensin I-converting enzyme (ACE) inhibitors, antiox

24 The angiotensin I-converting enzyme (ACE) inhibitory activit

25 In addition, the effects of digestion on the angiotensin I-converting enzyme (ACE) inhibitory activit

26 hiols content but at the same time increased angiotensin I-converting enzyme (ACE) inhibitory activit

27 The angiotensin I-converting enzyme (ACE) inhibitory activit

28 Angiotensin I-converting enzyme (ACE) inhibitory peptide

29 showed different amino acid compositions and angiotensin I-converting enzyme (ACE) inhibitory potenti

30 We determined the influence of angiotensin I-converting enzyme (ACE) insertion (I)/dele

31 Pedigree analyses have shown that angiotensin I-converting enzyme (ACE) levels are influen

32 Angiotensin I-converting enzyme (ACE), one of the centra

33 Although both LFHs <3 kDa showed in vitro angiotensin I-converting enzyme (ACE)-inhibitory activit

34 s established for oligopeptides that inhibit angiotensin I-converting enzyme (ACE).

35 ion (D) polymorphism (indel) of the gene for angiotensin I-converting enzyme (ACE).

36 Angiotensin I-converting enzyme (ACE)2, a new component

37 Angiotensin I-converting enzyme (ACE, or DCP1) is a zinc

38 Angiotensin I-converting enzyme (ACE, peptidyl dipeptida

39 Angiotensin-I converting enzyme (ACE) is a zinc dipeptid

40 Angiotensin-I converting enzyme (ACE) is a zinc metallop

41 egation analysis have shown that circulating angiotensin-I converting enzyme (ACE) levels are influen

42 Angiotensin-I converting enzyme (ACE), a two-domain dipe

43 -binding proteins were identified as porcine angiotensin-I-converting enzyme (ACE I) and aminopeptida

44 work in animals suggests that inhibitors of angiotensin-I-converting enzyme (ACE) protect against ca

45 l phenotype [C1Inh, C4, spontaneous amidase, angiotensin-I-converting enzyme (ACE), aminopeptidase P

46 eutral endopeptidase (NEP, EC 3.4.24.11) and angiotensin-I-converting enzyme (ACE, EC 2.4.15.1), have

47 Angiotensin-I-converting enzyme (ACE-I) plays a key role

48 Angiotensin-I-converting enzyme activities were 58 (44-7

49 as associated with a significant decrease in angiotensin I-converting enzyme activity and a small, bu

50 pairs, we identified 91 that had discordant angiotensin I-converting enzyme and glutathione S-transf

51 system gene regions (angiotensinogen, renin, angiotensin I-converting enzyme, and angiotensin II rece

52 nd an insertion/deletion polymorphism of the angiotensin I-converting enzyme gene (ACE) may be relate

53 An insertion polymorphism of the angiotensin-I converting enzyme gene (ACE) is common in

54 These results confirm the association of the angiotensin I-converting enzyme indel with Alzheimer's d

55 II type 1 receptor antagonist (AT1RA) and/or angiotensin I converting enzyme inhibitor (ACEI) were in

56 y HRV only in the 20 participants using ACE (angiotensin I-converting enzyme) inhibitors.

57 amino groups, GABA content, antioxidant and angiotensin I-converting enzyme inhibitory (ACEI) activi

58 ffect on proteolysis and negatively affected angiotensin I-converting enzyme inhibitory activity of f

59 acids), bioactivity (antioxidant effect and angiotensin I-converting enzyme inhibitory activity), rh

60 sweetness, bitterness and umami, as well as angiotensin-I converting enzyme inhibitory activity.

61 Angiotensin I converting enzyme (kininase II; ACE) inhib

62 eported previously a novel mode of action of angiotensin I-converting enzyme (kininase II; ACE) inhib

63 e N- and C-terminal domains of human somatic angiotensin I converting enzyme (sACE-1) demonstrate dis

64 Human somatic angiotensin I-converting enzyme (sACE) has two active si

65 Human somatic angiotensin I-converting enzyme (sACE) is a key regulato

66 nst alpha-glucosidase, pancreatic lipase and angiotensin I-converting enzyme, using in vitro models.